我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
5
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
1
20.0%
已完成
4
80.0%
暂无批准数据
- The FDA has issued a safety communication warning healthcare providers about serious complications from radiofrequency microneedling devices, including thermal burns, scarring, fat loss, and nerve damage. - These Class II medical devices, designed for skin rejuvenation and wrinkle reduction, have been associated with adverse events requiring surgical intervention or additional medical treatment. - The agency emphasizes that RF microneedling is a medical procedure requiring trained healthcare professionals, not a cosmetic treatment for home use. - Healthcare providers are advised to carefully assess treatment parameters, educate patients about risks, and report adverse events through the FDA's MedWatch system.